Tag
Specialty Chemicals
9 articles
Specialty chemical companies are navigating a mixed landscape of growth and challenges. Activist investors are pushing for change at Ashland, with Cruiser Capital urging a sale to unlock synergies, while Chemplast Sanmar reported a significant net loss due to impairments and market pressures. Conversely, several companies demonstrated robust growth, including SK Minerals (up 50%), Kshitij Polyline (up 46%), and Maximus International (up 18%), alongside dividend increases from Alkyl Amines (500%) and Vipul Organics (8%). The sector's resilience is also evident in the AI-driven partnership between Novyte and Chemvera, aiming to accelerate material development, and Gandhar Oil's continued revenue expansion despite geopolitical headwinds. These varied results highlight the need for strategic adaptation and investment to capitalize on emerging opportunities and mitigate ongoing risks.
Paushak Limited 53rd AGM Notice and Annual Report 2026
Paushak Limited submitted its 53rd Annual Report for FY ended March 31, 2026, recommending a dividend of ₹2.50 per share.
The AGM will be held on July 30, 2026 to approve financial statements, declare
Rossari Biotech FY26 Revenue Grows 15% to ₹23.96 Billion
Rossari Biotech reported 15% revenue growth to ₹23,964 million in FY26 with exports contributing 26% of total turnover and net profit increasing 9.4% to ₹1,492 million.
The company recommended a final
Chembond Material Technologies FY26 Revenue Up 25%
Chembond Material Technologies reported 25% revenue growth to ₹250.07 crore in FY26, though PBT declined 20% due to raw material cost pressures.
The company recommended a final dividend of ₹2.00 per s
Fairchem Organics FY26 Net Profit Declines 75%
Fairchem Organics reported a 75% YoY decline in net profit to ₹5.54 crore with revenue falling 14% to ₹459.65 crore for FY26.
The company completed a ₹34 crore share buyback of 425,000 shares at ₹800
Transpek FY26 Revenue Rs 645.7 Cr, Dividend ₹20/Share
Transpek reported FY26 revenue of Rs 645.7 Cr, impacted by subdued global demand and geopolitical volatility.
EBITDA stood at Rs 117.9 Cr with margins steady at 18.3%, while PAT declined 6.3% YoY to R
Alkyl Amines FY26 Results: ₹180 Crore Profit, 500% Dividend
Alkyl Amines reported FY26 revenue of ₹1,567.51 crores with net profit of ₹180 crores, declaring a 500% dividend of ₹10 per share.
The company will hold its 46th AGM virtually on July 3, 2026 to adopt
Kshitij Polyline FY2026 Revenue Up 46%, PAT ₹3.55 Crore
Kshitij Polyline reported FY2026 revenue growth of 46.3% to ₹44.75 crore and PAT of ₹3.55 crore versus FY2025 loss of ₹9.30 crore.
Completed full payment for Omkar Speciality Chemicals acquisition awa
Maximus International FY26 Revenue Up 18%, Record Q4
Maximus International reported 18% YoY revenue growth to ₹1848 Mn for FY26 with 14% EBITDA growth.
Q4 FY26 revenue surged 29% QoQ to ₹560 Mn with PAT of ₹22 Mn, up 12% from previous quarter.
The compa
Anupam Rasayan Open Offer for 26% Bliss GVS
Anupam Rasayan India Limited launched a mandatory open offer for 26% of Bliss GVS Pharma's expanded voting capital at ₹299 per share.
The offer, triggered by a Share Purchase Agreement to acquire a 43